WFDC2 and breast cancer: Our results indicated that plasma levels of HE4 expression in BC patients with distant metastasis (n=12) (P<0.01), lymphatic invasion (n=28) and lymph node metastasis (n=25) (for both P<0.05) significantly increased compared with non-metastatic BC patients (see Table 6 for the results).